Correction
20 Nov 2014: The PLOS ONE Staff (2014) Correction: Genital Human Papillomavirus Infection among Women in Bangladesh: Findings from a Population-Based Survey. PLOS ONE 9(11): e114655. https://doi.org/10.1371/journal.pone.0114655 View correction
Figures
Abstract
Background
There has been no population-based study on human papillomavirus (HPV) prevalence or its genotypes in Bangladesh; a country eligible for GAVI funding for HPV vaccine.
Methods
We used baseline survey data of a prospective cohort study that was conducted in one urban and one rural area of Bangladesh. A total of 997 urban and 905 rural married women, aged 13 to 64 years, were enrolled in the baseline during July-December, 2011. Information was collected on socio-demographic characteristics and potential risk factors for HPV infection followed by gynecological examination and collection of endocervical samples using the cervical cytobrush (Digene cervical sampler). HPV DNA testing was done by Polymerase Chain Reaction (PCR) using a consensus primer set.
Results
Prevalence of any HPV infection was 7.7% with no significant difference between urban and rural women. Most common high-risk genotypes were HPV16, HPV66, HPV18, HPV45, HPV31 and HPV53. Urban women working as housemaids or garment workers were at higher risk of any HPV infection (OR = 2.15, 95% CI: 1.13–4.11) compared to housewives. Rural women whose husband lived overseas were almost two times more likely to have any HPV infection (OR = 1.93; 95% CI 1.05–3.55) compared to women whose husbands lived with them.
Conclusion
The prevalence of HPV infection among Bangladeshi women is similar to other regions of Asia. However, type-specific patterns are different. The study findings will inform the formulation of HPV vaccination policies in Bangladesh, monitoring the impact of vaccination programmes, and the identification of target populations for screening.
Citation: Nahar Q, Sultana F, Alam A, Islam JY, Rahman M, Khatun F, et al. (2014) Genital Human Papillomavirus Infection among Women in Bangladesh: Findings from a Population-Based Survey. PLoS ONE 9(10): e107675. https://doi.org/10.1371/journal.pone.0107675
Editor: Xuefeng Liu, Georgetown University, United States of America
Received: April 15, 2014; Accepted: August 13, 2014; Published: October 1, 2014
Copyright: © 2014 Nahar et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: The authors confirm that all data underlying the findings are fully available without restriction. The data are owned by the icddr,b and requests for the data may be sent to the Data Centre Committee of icddr,b (http://www.icddrb.org/) mentioning the corresponding author's name of the study.
Funding: This work was funded by the Swedish International Development Cooperation Agency (Sida, www.sida.org): Sida contribution numbers 54100020 and 51060029. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Cervical cancer is a major public health problem worldwide. It is the fourth most common cancer in women with an estimated 527,624 new cases and 265,653 deaths in 2012 [1]. Around 85% of these new cases and 86% of deaths occur in less developed countries [2]. In Bangladesh, cervical cancer is the second most common cancer among females with an estimated 11,956 new cases and 6,582 deaths in 2012 [3].
Human papillomavirus (HPV) is one of the most commonly acquired sexually transmitted infections (STIs) and a significant source of morbidity and mortality [4], [5]. Persistent infection with certain types of HPV is a necessary cause of cervical cancer [6]. The World Health Organization has defined 12 HPV types (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58 and 59), as high-risk (HR) or cancer-causing types and some other subtypes (68, 73, 26, 30, 53, 66, 67, 69, 82 and 85) as possible cancer-causing types [7]. Of these, HPV16 and HPV18 account for at least 71% of all cases of cervical cancer worldwide [8]. The other types (6, 11, 13, 40, 42, 43, 44, 54, 61, 70, 72, 81 and 89) that are mostly linked to genital warts are classified as “low-risk” (LR) types [9].
The prevalence of HPV infection has shown to vary by region, country and within a country by population sub-groups [10]. While the estimated global HPV prevalence is reported to be 11.7%, country specific prevalence ranges between 1.6% and 41.9% [11]. HPV prevalence is higher (14.3%) in developing regions than developed regions (10.3%). Type-specific distribution of HPV infection also varies by geographic region [12], [13]. Some HPV types are more prevalent in the Asia Pacific region than other regions [14].
The literature identifies several risk factors for the acquisition and persistence of HPV infection. Age is a strong predictor, although there are notable differences in age curves of HPV infection across regions [15]–[17] Other factors include number of recent/lifetime sexual partners, age at onset of sexual activity, socioeconomic status, male circumcision, condom use, oral contraceptive use, smoking [4], [18]–[25], use of public bathhouses [26] and low education [27]. High parity was also identified as a risk factor for HR-HPV infection [28].
While some epidemiological research on HPV has been conducted in the South Asian region [29], only a few studies have reported HPV prevalence among selected populations in Bangladesh such as female sex workers [30] and cancer patients in tertiary level hospitals [31], [32]. Moreover, there have been no systematic population-based studies to estimate HPV prevalence or risk factors for HPV infection in Bangladesh [33]. Previous systematic reviews have postulated the prevalence of HPV in South Asian countries and region to be lower than other areas of the world [10]. Similarly, we hypothesized HPV prevalence to be similar to those found in India and other neighboring countries. In this paper, we report the results from a baseline survey of a population-based prospective cohort study of the type-specific and age-specific distribution of HPV infection and its risk factors among ever-married women in an urban and a rural area of Bangladesh.
Materials and Methods
Study Population and Sampling
The baseline survey was conducted between July and December 2011 and was implemented in two areas of Bangladesh; one rural and one urban (Figure 1a). The urban area is located in Dhaka, the capital of Bangladesh, which is the largest metropolitan city in the country. Dhaka city is divided into 92 administrative wards (smallest administrative urban geographic unit), each with an approximate population of 90,000 or more. The International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), an international research organization, has maintained a surveillance site for one of its on-going research projects since 2010 in Ward 2 (Figure 1b) covering a population of approximately 27,000. For the purpose of surveillance, Ward 2 is divided into 9 clusters. For this study, we purposely selected 3 of these 9 clusters. All ever-married women aged 13–64 years and living in these three clusters (n = 4,484) constituted the sampling frame for the urban component of the study.
The rural site of the study is located in Mirzapur, a sub-district of Tangail district, which is 56 kilometers northwest of Dhaka. In Mirzapur, icddr,b has been running a demographic surveillance since 2007 covering a population of approximately 240,000 in eight unions (smallest administrative rural geographic unit comprising of mauzas and villages and having union parishad institution). We purposely selected two of the eight unions (Figure 1c) that comprised a total of 35 villages and then randomly selected eight of these villages. All ever-married women aged 13–64 years (n = 5,222) from these eight villages constituted the sampling frame for the rural site.
Using systematic random sampling, every third woman in the sampling frame in both urban and rural areas was approached and asked to participate in the study. In the field, the selected women were identified by their name and address recorded in the listing database (urban site) or in the surveillance data base (rural). In both the urban and rural areas, the clusters and villages under study were purposely selected for feasibility issues considering proximity to icddr,b’s field offices, logistics and cost-related issues.
Ethics Statement.
The study protocol was approved by the Ethical Review Committee (ERC) of icddr,b. Informed written consent was taken from women aged 18–64 years whereas informed written assent was taken from women aged 13–17 years. For the later group, the assent form was read out to these women in the presence of their parents/legal guardians. If agreed, the assent form was then signed by the participants in the presence of their parents/guardians. The parents/guardians signed the same form.
Data Collection
In both study areas, women were first approached at their home and eligibility was determined by trained female research staff. They were briefed about the study background and purpose, and the potential roles they would have in the study. Women who were eligible and willing to participate were sent to a study field office for interview, clinical examination and sample collection. In the case of a refusal, the next eligible woman on the list was approached.
Upon arrival at the study field office, a female study physician provided them with detailed information about the study process including the process for collecting the cervical sample. On agreeing to participate in the study, the women were further screened for eligibility criteria by the physician; upon meeting these criteria they were then taken to the next room for interview. Women who were pregnant, or post-partum, or with a history of hysterectomy, cervical cancer or uterine prolapse were excluded from the study. Women with major psychological/psychiatric problems were also excluded.
After informed, voluntary, written consent or assent, six trained female research assistants collected information on socio-demographic characteristics (age, education, occupation, marital status, age at marriage, husband’s residency, and monthly household expenditure), sexual and reproductive history (parity, number of life-time sex partners, number of husband’s life-time sex partners) and other risk factors, such as use of oral contraceptives, tobacco and condom use. Two trained female research physicians performed clinical examinations, including visual examination of the vulva. Following this, the speculum was inserted and the vagina and cervix were examined for any discharge, erosion or lesions. The physician then collected cervical samples using the cervical cytobrush (Rovers, Cervex-Brush, Oss, The Netherlands). Following sample collection slides for cervical cytology were prepared The head of the brush was then detached in 10 ml BD SurePath (BD Diagnostics, Burlington, NC, USA) and stored at 4°C. The specimens (including slides) were then transported to the virology laboratory of icddr,b maintaining appropriate temperature and stored at 4°C until tested. While HPV DNA testing was performed at icddr,b, the cervical slides were sent to the pathology department of Bangabandhu Sheikh Mujib Medical University (BSMMU) for testing. The results of both the HPV DNA test and cervical cytology were provided to the study participants within 2–4 weeks of sample collection. Women presenting the possibility of precancerous or cancerous changes were referred to BSMMU for further assessment and treatment. The details of cervical cytology will be published elsewhere.
HPV Testing
Sample processing and DNA extraction.
A 6ml aliquot of cervical swab sample was centrifuged at 5000rpm for 15 min. After decanting the supernatant, the pellet was resuspended in 500 µl phosphate buffer saline. DNA extraction was carried out with a 200 µl aliquot of this concentrated sample using a DNeasy Blood and Tissue Kit (Qiagen, Hilden, Germany) according to the manufacturer’s instructions. The extracted DNA was stored at −20°C until tested.
HPV genotyping was carried out in three steps: 1) Detection of HPV L1 gene using PCR; 2) Genotyping using nucleotide sequencing, and 3) Identification of co-infection and genotypes of a small number of HPV positive cases for which typing could not be done in step 2.
Detection of HPV L1 gene using PCR.
The first round of PCR amplification was carried out in a 25 µl reaction volume containing 10 µl extracted DNA as a template, 2.5 µl Qiagen 10× PCR buffer, 0.25 µl Hotstar Taq polymerase (Qiagen, Hilden, Germany) (5 U/µl), and 20 pmol papillomavirus specific consensus primers MY09/MY11 [34] and 10 mM of each dNTPs. This reaction mixture was preheated at 95°C for 15 min for polymerase activation and amplified for 40 cycles under the following conditions: denaturation at 94°C for 20 s, annealing at 55°C for 20 s and extension at 72°C for 40 s, plus a final extension step at 72°C for 7 min. One microlitre from the first PCR was further amplified with the inner pair of primers GP5+/GP6+ [35] in a 25 µl reaction mixture. The second round of amplification was performed as follows: 94°C for 60 s, 60°C for 60 s and 72°C for 60 s, plus an additional final extension step at 72°C for 5 min.
Genotyping using nucleotide sequencing.
HPV positive PCR products either visible in the first or second PCR round were sequenced using respective PCR-product primers with a Big-Dye Xterminator ready reaction kit v3.1 (Applied Biosystems, Foster City, CA. USA) in an ABI 3500xL genetic analyser (Applied Biosystems, Foster City, ca. USA). Genotyping of HPV was inferred by comparing the resulting sequence for each sample to the GenBank database using BLAST (Basic Local Alignment Search Tool). This method identified HPV types in all samples except six.
Identification of co-infections.
To identify co-infections, all HPV positive samples were reassessed with a commercially available real time PCR kit (Hybribio HPV Detection Kit, Hybribio Ltd, Wanchai, Hong Kong). The test specifically identifies HPV16 and HPV18 while concurrently detecting the rest of the 10 high risk types (31,33,35,39,45,51,52,56,58,59) and two possible high-risk type (66, 68) in a pooled result (other HR-HPV other than 16/18) and any of the 5 LR-HPV types (6,11,42,43,44). The reassessment also assisted us to identify genotypes of six HPV positive cases for which typing could not be done using PCR sequencing in step 2.
To verify the presence of human genomic DNA in samples, a 268 bp fragment of the β-globin housekeeping gene was amplified using primers GH20 (5′-CAACTTCATCCACGTTCACC-3′), PC04 (5′-GAAGAGCCAAGGACAG GTAC-3′) and HMBB01 (5′-GCGACCCAATGCAAATTGGT-3′) [36]. This process was critical to verifying the presence of adequate cervical epithelial cells in the sample to be tested for HPV.
Statistical Analysis
Descriptive analyses were performed to compare women in rural and urban areas by their socio-demographic group, reproductive history and other variables such as age, education, occupation, parity, number of sexual partners, use of oral contraceptives, use of condoms and use of tobacco. Test of significance was performed using Chi-square or Fisher’s test with a 5% level of significance. The prevalence of “any HPV” infection was calculated as the proportion of women testing positive for any type of HPV infection. Frequency distribution of type-specific information of HR-HPV positive cases was also collated. In the calculation of prevalence for HR-HPV infection, women who were co-infected with HR-HPV and LR-HPV were categorized as HR-HPV positive cases and included in the calculation of HR-HPV type prevalence. Age-specific distribution of any HPV infection, LR-HPV and HR-HPV infections were calculated separately for urban and rural women.
Two forward step-wise multivariate logistic regression models were generated separately for urban and rural women to estimate adjusted odds ratios with 95% confidence intervals using “Any HPV infection” and “HR-HPV infection” as dependent variables. In the first model with “Any HPV infection” as the dependent variable, all women tested positive for any HPV infection were coded as “1” and the rest were coded as “0”. Similarly, in the second model, all women who tested positive for HR-HPV infection, either single or co-infection, were coded as “1” and the rest were coded as “0”. Due to the sampling design and possible effect modification, data analyses were carried out separately for urban and rural samples. Statistical analyses were performed using SPSS, version 17.0 and STATA/SE 12.0.
Results
In the urban area, a total of 1,855 eligible women were approached of which 1,152 (62%) agreed to participate; interviews were completed and samples collected for 1,113 (97%) women. Out of these, 997 women were currently married and having an active sexual relationship with their husband. Similarly, in the rural area, a total of 1,499 eligible women were approached, of which 1,159 (77%) agreed to participate. Interviews were completed and samples collected from 924 (80%) women, of whom 905 women were currently married and having an active sexual relationship with their husband. The rest of the women who were approached but not included in this study either refused to take part (n = 597; 18%), did not show up in the project office on the scheduled day of interview (n = 330; 10%), or were found ineligible after examination by the study physicians (n = 390; 12%). Of the women who were interviewed and from whom samples were collected, some were either divorced, widowed or separated at the time of the interview (n = 135; 7%) and information on their husband’s residence or condom use was not appropriate to collect and therefore, these women were excluded from the analysis.
Background characteristics
Table 1 shows background characteristics of women in the study. More than half of the women were between 25 and 44 years of age with no significant difference in mean age between urban and rural women. More urban women than rural women had completed secondary education or higher (31% versus 12%), were working (29% versus 7%; p<0.01) and had a median monthly household expenditure (16,872 versus 8,790 Bangladeshi taka [BDT]; 1 US$ = 78 BDT; p = 0.000). A significant percentage of urban women worked as garment workers or housemaids (14%) compared to rural women (<1%; p<0.001). Urban women also had a higher mean age at marriage compared to rural women (17.4 years versus 16.0 years; p = 0.000).
While the majority of women resided with their husbands in both areas (88% of urban and 74% of rural women), a higher proportion of rural women had a husband living overseas (18%) compared to urban women (6%). About half of the women had three or more children with no difference in the mean number of children between urban and rural women. Most women in both areas reported one lifetime sex partner. While the majority of women reported their husband to have one lifetime sex partner, one in five women reported their husband as having more than one lifetime sex partner, with no difference between urban and rural women. Ever use of oral contraceptives was slightly higher among rural women compared to urban women (87% versus 82%; p = 0.002); whereas ever use of condoms was significantly higher among urban women compared to rural women (58% versus 33%; p = 0.000).
Prevalence of HPV infection
Overall, the prevalence of any HPV infection was 7.7% with no significant difference between urban and rural women (7.9% and 7.5% respectively; p = 0.87). A total of 93 women had single-type HPV infection (4.9% overall and 64.1% of HPV positive women) and 52 women had multiple HPV infection (2.7% overall and 35.9% of HPV positive women). HR-HPV infections, single and co-infection combined, were more common (4.2%) than LR-HPV infections (3.4%) with no significant variation between urban and rural women. The most commonly found HR-HPV types in either single or co-infection were HPV16, HPV66, HPV18, HPV45, HPV31 and HPV53. Other HR-HPV types included HPV33, HPV35, HPV52 and HPV58 (Figure 2).
Age-specific prevalence of any HPV infection and infection by HR and LR-HPV types are shown in Figure 3a and b. Age-specific prevalence of any HPV infection was slightly different for urban and rural women. For urban women, age-specific prevalence decreased from 10.4% for 24 years of age or younger to 6.9% for 25–34 years of age; thereafter, prevalence increased to 8.4% at 35–44 years and then decreased again to 5.8% for women 45 years and older (Figure 3a). Infection by HR types dominated LR types for urban women in all age groups; however, the differences were most marked in the oldest age group.
A slightly different HPV infection pattern was observed for rural women. Age-specific prevalence decreased from 9.3% at 24 years or below to 8.3% and 4.4% respectively for the next two age groups of 25–34 and 35–44 years; thereafter, it increased to 7.5% for women aged 45 years and older (Figure 3b). When stratified by type of HPV infection, we found HR infection to decrease with age and to be relatively stable after 35 years, while LR infection decreased with age until 35–44 years and thereafter, increased in older women (45 years and older).
Risk factors for HPV infection
Table 2 presents results from multivariate logistic regression models of risk factors associated with any HPV infection and those associated with HR-HPV infection. After controlling the effects of other factors in the model, we did not find any effect of age on any HPV infection or HR-HPV infection. Education was found to have a varied effect on HPV infection by study site. While no effect of education was seen on HPV infection (any or HR-HPV) in urban women, having primary, secondary or higher education significantly decreased the risk of any HPV infection in rural women (OR = 0.46, 95% CI 0.23–0.92; OR = 0.34, 95% CI 0.12–0.98 respectively) when compared to those who had no education. The risk of getting HR-HPV infection was even lower for these women if they had primary education (OR = 0.34, 95% CI 0.14–0.83); however, no effect of completing secondary or higher education was seen on HR-HPV infection in rural women.
Occupation had the strongest effect on HPV infection for urban women. Urban women who were working as housemaids or garment workers were at higher risk of any HPV infection (OR = 2.15, 95% CI: 1.13–4.11) compared to those who reported being housewives. The risk doubled for infection with HR-HPV subtypes (OR = 4.11, 95% CI: 1.80–9.40) for this group of women.
Parity was found to be associated with any HPV infection for rural women only. In particular, having three or more children lowered the risk of any HPV infection for rural women (OR = 0.28; 95% CI 0.09–0.80). Similarly, husband’s residency status was found to be associated with any HPV infection for rural women. Rural women whose husband lived overseas were almost twice as likely to have any HPV infection (OR = 1.93; 95% CI 1.05–3.55) compared to those women whose husbands lived with them.
The number of lifetime sex partners of urban women was significantly associated with detection of any HPV infection; women reporting two or more partners were almost four times more likely to have any HPV infection compared to those reporting only one sex partner (OR = 3.80, 95% CI: 1.79–8.08). We did not find any association between the numbers of lifetime sex partners of women with HR-HPV infection. We also did not find any association between the number of the husband’s sex partners with the risk of any HPV infection or HR-HPV infection. No effect of contraceptives or tobacco use was found in our analysis. We did not have enough rural samples to investigate the effect of occupation or number of sexual partners on HPV status.
Discussion
To the best of our knowledge, this is the first study to investigate the prevalence of HPV infection and its type-specific distribution in population-based samples of urban and rural women in Bangladesh. The overall prevalence of any HPV infection was found to be 7.7% in this study. This is similar to the prevalence reported in other Asian countries –9% in Nepal [37], 6.7% in China [38] 9.1% in Thailand [39] and 11.4% in Indonesia [40].
HR-HPV was more common than LR-HPV infection in almost all age groups, except among rural women older than 44 years. HPV16 was the most frequently detected type, as found in other parts of the world, including Asia [14]. However, the other HR types found in our study were somewhat different than the types found among female sex workers in Bangladesh [33] and in other Asian countries. HPV66 was the second most common type followed by HPV18 in our study, while HPV18 followed by HPV33 were most commonly found among female sex workers [33]. HPV58 was the second most common HR type reported in other Asian countries [14]. Other prevalent types in the region are HPV18, HPV31, HPV33, HPV35, HPV39, HPV45, HPV51, HPV52 and HPV56 [14] compared to HPV18, HPV45, HPV31 and HPV53 in our study.
Similar to other countries, we found HPV infection to be most common in younger women with the peak prevalence occurring in women younger than 25 years of age; prevalence started to decline after 30 years of age. We found a secondary increase after age 44 for rural women and ages 35–44 for urban women. In Bangladesh girls marry at an early age and the study was conducted among married women. This may explain high HPV infection in the younger age group. However, the secondary peak seen during 35–44 years in urban women and 45–64 years for rural women requires further explanation.
Bangladesh has made remarkable progress in terms of population, economic and health indicators in recent years [41]. There are several factors that indicate an improvement in Bangladesh’s social sector, such as rising educational levels, particularly in women [42]–[44], and increased economic opportunities, especially in urban areas. The garment industry accounts for approximately 80% of the country’s total exports and roughly 85% of the workers in the garment industry are women. For women, this has led to increased employment and empowerment but also exposure to changing social dynamics and environments that may increase their engagement in intimate relationships [45] and sexual exploitation [46], [47], thereby increasing their likelihood of HPV infection. This may explain the significant effect of women’s occupation on HPV infection in the urban setting of this study.
Occupation was also a significant predictor for HPV infection in the rural study site. In this case however, it was the risk posed by the occupation of women’s husbands. Economic opportunities outside of Bangladesh draw rural men to leave their families for long periods of time for work overseas. This may increase their opportunity for engaging in risky sexual behaviors, thus increasing their wives vulnerability to HPV infection. All these factors may help to explain the secondary peak of HPV infection in our study in women in their late 30′s and 40′s.
While we found a similar prevalence of any HPV infection and HR-HPV infections among rural and urban women, we found some important differences in risk factors for infection between rural and urban women. Education had a protective effect for rural women, but not for urban women. Urban women working as garment workers or housemaids were at an increased risk of HPV infection. For urban women, the number of sexual partners was highly associated with HPV infection, a finding consistent with other settings [48]. This finding is also in agreement with that from a previous study conducted in Bangladesh where duration of sex work as interpreted as increased number of sex partners was found to be a strong predictor for HPV infection [33].
Another common economic opportunity for women in urban areas is to work as domestic servants or housemaids. This occupation may also expose women to increased risk of sexual exploitation as supported by other studies [49], [50]. It is important to note that occupation is a significant risk factor for urban women in our study. This may suggest the importance of using garment factories as entry points for HPV education and screening programmes for cervical cancer.
We did not find any association between oral contraceptive use with HPV infection as found in other studies [48], [51]. This lack of association may be partially explained by the fact that we collected information on use at any point in the women’s life-time (ever-use) and not current use or duration of use. Similarly, our analysis did not demonstrate the beneficial effect of condom use in protecting against HPV infection as shown in other studies [52], [53]. This may be due to the very low rates of condom use in the country [54]. There was also a lack of association between tobacco use and HPV infection, which is again contrary to the current knowledge that smoking increases the risk of HPV infection [5], [51]. Very low use of tobacco among the study population may explain this finding. The lack of association between condom use and tobacco consumption and HPV infection needs further investigation.
Our study used population-based socio-economically diverse samples from two existing surveillance systems. However, limited participation (62% of sample in urban and 77% of rural sample) may raise questions about the representativeness of the study findings. To address this, we examined the basic socio-demographic characteristics of those participating in the study and those who did not, and we found the two groups to be similar, suggesting limited plausibility for selection bias.
Our study adds immense value to the existing knowledge of the burden of HPV infection among the selected urban and rural female population in Bangladesh. The identification of genotypic distribution will help further understanding of the risk of developing cervical cancer in the study population. While we found HPV16 to be the predominant type, HPV66 was the second major HR-HPV type identified in our study population, followed by HPV18. Epidemiological evidence of the carcinogenicity of HPV66 was previously judged sufficient; however, HPV66 has rarely been identified in populations [55]. The currently licensed vaccines do not include HPV66 and it is unknown how these vaccines will perform against this type, which appears to be common among Bangladeshi women.
Given that HPV infection is a necessary cause of cervical cancer and preventing it is the most effective way to prevent cervical cancer. HPV vaccines have been proven to be an effective and safe measure to prevent HPV infection and disease related to the vaccine-specific genotypes in women with no evidence of past or current HPV infection [56], [57]. Recent population-based studies have confirmed these findings [58], [59]. Based on the results of these previously published studies, we can be certain that the introduction of a vaccine against HPV16 and HPV18 will reduce the bulk of cervical lesions in Bangladeshi women, as has been seen in other countries such as Australia [60].
This study provides the first population-based HPV prevalence data in Bangladesh. While the findings are similar to studies from neighboring countries, the type-specific distribution, as well as identification of risk factors will provide additional evidence to guide Bangladesh’s response through a cervical cancer prevention programme. The findings are especially timely as the Government of Bangladesh is planning to apply to the Global Alliance for Vaccines and Immunization (GAVI) for funding for pilot testing of the HPV vaccine in a peri-urban setting. The evidence from this study will provide necessary country-specific evidence for this application.
Acknowledgments
We acknowledge the support received from Kumudini Hospital, Mirzapur, Tangail and Concerned Women for Family Development, Dhaka for providing office space for the study. We appreciate the support received from Bangabandhu Sheikh Mujib Medical University (BSMMU) for cervical cytology testing and the services provided to those women in the study who presented with cytological abnormalities. We greatly appreciate the support provided by Musarrat Rubina Mannan and Iffat Sharmin in smooth running of project in two field sites. We also acknowledge the contribution of Md. Mokbul Hassan Afrad, A.J.M. Zehadee Momtaz and A.F.M. Rajibur Rahman by providing the laboratory support. We thank Dr. Firdausi Qadri, Dr. ASG Faruque and Dr. Shams El Arifeen from icddr,b for allowing us to use surveillance data to create the sampling frame for the study. We appreciate the editorial support provided by Ian Shepherd.
Author Contributions
Conceived and designed the experiments: QN FS AA JYI MR FK NA SKD LM AN MK AC LR. Performed the experiments: QN FS AA JYI MR FK NA SKD LM AN MK AC LR. Analyzed the data: QN JYI. Contributed reagents/materials/analysis tools: QN FS AA FK NA SKD LR. Contributed to the writing of the manuscript: QN FS AA JYI MR FK NA SKD LM AN MK AC LR.
References
- 1.
GLOBOCAN (2012) GLOBOCAN 2012: Population Fact Sheets World. GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012.
- 2.
GLOBOCAN (2012) GLOBOCAN 2012: Population Fact Sheet - Less Developed Regions. GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012.
- 3.
GLOBOCAN (2012) GLOBOCAN 2012: Population Fact Sheet - Bangladesh GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012.
- 4. Baseman JG, Koutsky LA (2005) The epidemiology of human papillomavirus infections. Journal of clinical virology: the official publication of the Pan American Society for Clinical Virology 32 Suppl 1S16–24.
- 5. Asiaf A, Ahmad ST, Mohammad SO, Zargar MA (2013) Review of the current knowledge on the epidemiology, pathogenesis, and prevention of human papillomavirus infection. Eur J Cancer Prev 23(3): 206–24.
- 6. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV (2002) The causal relation between human papillomavirus and cervical cancer. Journal of clinical pathology 55: 244–265.
- 7. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, et al. (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. The New England journal of medicine 348: 518–527.
- 8. de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, et al. (2010) Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. The lancet oncology 11: 1048–1056.
- 9. Muñoz N, Castellsagué X, de González AB, Gissmann L (2006) Chapter 1: HPV in the etiology of human cancer. Vaccine 24 Supplement 3S1–S10.
- 10.
Smith JS, Melendy A, Rana RK, Pimenta JM (2008) Age-specific prevalence of infection with human papillomavirus in females: a global review. The Journal of adolescent health: official publication of the Society for Adolescent Medicine 43: S5–25, S25 e21–41.
- 11. Bruni L, Diaz M, Castellsague X, Ferrer E, Bosch FX, et al. (2010) Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. The Journal of infectious diseases 202: 1789–1799.
- 12. Clifford GM, Gallus S, Herrero R, Munoz N, Snijders PJ, et al. (2005) Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 366: 991–998.
- 13. de Sanjose S, Diaz M, Castellsague X, Clifford G, Bruni L, et al. (2007) Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. The Lancet infectious diseases 7: 453–459.
- 14. Garland SM, Cuzick J, Domingo EJ, Goldie SJ, Kim YT, et al. (2008) Recommendations for cervical cancer prevention in Asia Pacific. Vaccine 26 Suppl 12M89–98.
- 15. Franceschi S, Herrero R, Clifford GM, Snijders PJ, Arslan A, et al. (2006) Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. International journal of cancer Journal international du cancer 119: 2677–2684.
- 16. Insinga RP, Glass AG, Rush BB (2004) Diagnoses and outcomes in cervical cancer screening: a population-based study. American journal of obstetrics and gynecology 191: 105–113.
- 17. Kjaer SK, van den Brule AJ, Bock JE, Poll PA, Engholm G, et al. (1997) Determinants for genital human papillomavirus (HPV) infection in 1000 randomly chosen young Danish women with normal Pap smear: are there different risk profiles for oncogenic and nononcogenic HPV types? Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 6: 799–805.
- 18. Moscicki AB, Hills N, Shiboski S, Powell K, Jay N, et al. (2001) Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. JAMA: the journal of the American Medical Association 285: 2995–3002.
- 19. Richardson H, Franco E, Pintos J, Bergeron J, Arella M, et al. (2000) Determinants of low-risk and high-risk cervical human papillomavirus infections in Montreal University students. Sexually transmitted diseases 27: 79–86.
- 20. Winer RL, Lee SK, Hughes JP, Adam DE, Kiviat NB, et al. (2003) Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. American journal of epidemiology 157: 218–226.
- 21. Cotton SC, Sharp L, Seth R, Masson LF, Little J, et al. (2007) Lifestyle and socio-demographic factors associated with high-risk HPV infection in UK women. British journal of cancer 97: 133–139.
- 22. Tobian AA, Serwadda D, Quinn TC, Kigozi G, Gravitt PE, et al. (2009) Male circumcision for the prevention of HSV-2 and HPV infections and syphilis. The New England journal of medicine 360: 1298–1309.
- 23. Marks M, Gravitt PE, Gupta SB, Liaw KL, Tadesse A, et al. (2011) Combined oral contraceptive use increases HPV persistence but not new HPV detection in a cohort of women from Thailand. The Journal of infectious diseases 204: 1505–1513.
- 24. Roset Bahmanyar E, Paavonen J, Naud P, Salmeron J, Chow SN, et al. (2012) Prevalence and risk factors for cervical HPV infection and abnormalities in young adult women at enrolment in the multinational PATRICIA trial. Gynecologic oncology 127: 440–450.
- 25. Liao SF, Lee WC, Chen HC, Chuang LC, Pan MH, et al. (2012) Baseline human papillomavirus infection, high vaginal parity, and their interaction on cervical cancer risks after a follow-up of more than 10 years. Cancer causes & control: CCC 23: 703–708.
- 26. Zhao FH, Forman MR, Belinson J, Shen YH, Graubard BI, et al. (2006) Risk factors for HPV infection and cervical cancer among unscreened women in a high-risk rural area of China. International journal of cancer Journal international du cancer 118: 442–448.
- 27. Mitchell SM, Sekikubo M, Biryabarema C, Byamugisha JJ, Steinberg M, et al. (2014) Factors associated with high-risk HPV positivity in a low-resource setting in sub-Saharan Africa. American journal of obstetrics and gynecology 210: 81 e81–87.
- 28. Sun LL, Jin Q, Li H, Zhou XR, Song ZQ, et al. (2012) Population-based study on the prevalence of and risk factors for human papillomavirus infection in Qujing of Yunnan province, Southwest China. Virology journal 9: 153.
- 29. Bhatla N, Lal N, Bao YP, Ng T, Qiao YL (2008) A meta-analysis of human papillomavirus type-distribution in women from South Asia: implications for vaccination. Vaccine 26: 2811–2817.
- 30. Huq M, Nahar S, Alam A, Imam H, Rahman M (2012) The prevalence of selected high-risk human papillomavirus infections among female sex workers in Dhaka, Bangladesh. International journal of STD & AIDS 23: 151–152.
- 31. Banik U, Ahamad MS, Bhattacharjee P, Adhikary AK, Rahman Z (2013) High risk human papillomavirus type 16 and 18 infection in the cervical lesions of women with epithelial cell abnormality in Pap smear: A cytohistomorphologic association in Bangladeshi women. CytoJournal 10: 14.
- 32. Khatun S, Syed MAH, Hossain F, Choudhury A (2009) Human Papillomavirus and other risk factors in carcinoma cervix. Bangladesh Med J 38: 18–23.
- 33. Sankaranarayanan R, Bhatla N, Gravitt PE, Basu P, Esmy PO, et al. (2008) Human papillomavirus infection and cervical cancer prevention in India, Bangladesh, Sri Lanka and Nepal. Vaccine 26 Suppl 12M43–52.
- 34.
Bauer HM, Greer C, Manos MM (1992) Determination of genital HPV infection using consensus PCR. In: Herrington CS, McGee JOD, editors. Diagnostic Molecular Pathology: a Practical Approach. Oxford, United Kindom: Oxford United Press. pp. 132–152.
- 35. Jacobs MV, Snijders PJ, van den Brule AJ, Helmerhorst TJ, Meijer CJ, et al. (1997) A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. Journal of clinical microbiology 35: 791–795.
- 36. Saiki RK, Bugawan TL, Horn GT, Mullis KB, Erlich HA (1986) Analysis of enzymatically amplified beta-globin and HLA-DQ alpha DNA with allele-specific oligonucleotide probes. Nature 324: 163–166.
- 37. Sherpa AT, Clifford GM, Vaccarella S, Shrestha S, Nygard M, et al. (2010) Human papillomavirus infection in women with and without cervical cancer in Nepal. Cancer causes & control: CCC 21: 323–330.
- 38. Zhao R, Zhang WY, Wu MH, Zhang SW, Pan J, et al. (2009) Human papillomavirus infection in Beijing, People’s Republic of China: a population-based study. British journal of cancer 101: 1635–1640.
- 39. Sukvirach S, Smith JS, Tunsakul S, Munoz N, Kesararat V, et al. (2003) Population-based human papillomavirus prevalence in Lampang and Songkla, Thailand. The Journal of infectious diseases 187: 1246–1256.
- 40. Vet JN, de Boer MA, van den Akker BE, Siregar B, Lisnawati, et al (2008) Prevalence of human papillomavirus in Indonesia: a population-based study in three regions. British journal of cancer 99: 214–218.
- 41.
Bangladesh Bureau of Statistics (2012) Bangladesh Bureau of Statistics Economic Survey of Bangladesh 2012. Dhaka, Bangladesh: Statistics and Informatics Division, Ministry of Planning, Government of the People’s Republic of Bangladesh.
- 42.
Nazneen SHN, Sultan M (2011) National Discourses on Women’s Empowerment in Bangladesh: Continuities and Change. Brighton, UK: Institute of Development Studies. pp. 41.
- 43.
UNICEF (2008) Bangladesh: Unite for Children. In: UNICEF, editor editors. pp. 19.
- 44. Hossain NKN (2004) Achieving Universal Primary Education and Eliminating Gender Disparity. Economic and Political Weekly 39: 4093–4100.
- 45.
Muna L (2005) Romance and pleasure; understanding the sexual conduct of young people in Dhaka in the era of HIV and AIDS. University Press Limited. 183 p.
- 46. Kibria N (1995) Culture, Social Class and Income Control in the Lives of Women Garment Workers in Bangladesh. Gender and Society 9: 289–309.
- 47. Ahmed F (2004) The Rise of the Bangladesh Garment Industry: Globalozation, Women Workers and Voice NWSA Journal. 16: 34–45.
- 48. Chelimo C, Wouldes TA, Cameron LD, Elwood JM (2013) Risk factors for and prevention of human papillomaviruses (HPV), genital warts and cervical cancer. The Journal of infection 66: 207–217.
- 49.
Selim N (2009) Domestic Service in Bangladesh: A Case Study in Dhaka. Dhaka, Bangladesh: Sahitya Prakash.
- 50.
Akter N (2006) Domestic Maids in Bangladesh: Health Hazards of Domestic Maids in Dhaka. International Studies Association, Town & Country Resport and Convention Center. San Diego, California.
- 51. Vinodhini K, Shanmughapriya S, Das BC, Natarajaseenivasan K (2012) Prevalence and risk factors of HPV infection among women from various provinces of the world. Archives of gynecology and obstetrics 285: 771–777.
- 52. Vaccarella S, Franceschi S, Herrero R, Munoz N, Snijders PJ, et al. (2006) Sexual behavior, condom use, and human papillomavirus: pooled analysis of the IARC human papillomavirus prevalence surveys. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 15: 326–333.
- 53. Manhart LE, Koutsky LA (2002) Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis. Sexually transmitted diseases 29: 725–735.
- 54.
Kamal SM, Hassan CH, Salikon RH (2013) Safer Sex Negotiation and Its Association With Condom Use Among Clients of Female Sex Workers in Bangladesh. Asia-Pacific journal of public health/Asia-Pacific Academic Consortium for Public Health.
- 55. Schiffman M, Clifford G, Buonaguro FM (2009) Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline. Infectious agents and cancer 4: 8.
- 56. Macartney KK, Chiu C, Georgousakis M, Brotherton JM (2013) Safety of human papillomavirus vaccines: a review. Drug safety: an international journal of medical toxicology and drug experience 36: 393–412.
- 57. Franco EL, Cuzick J, Hildesheim A, de Sanjose S (2006) Chapter 20: Issues in planning cervical cancer screening in the era of HPV vaccination. Vaccine 24 Suppl 3S3/171–177.
- 58. Brotherton JM, Fridman M, May CL, Chappell G, Saville AM, et al. (2011) Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study. Lancet 377: 2085–2092.
- 59. Gertig DM, Brotherton JM, Budd AC, Drennan K, Chappell G, et al. (2013) Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study. BMC Med 11: 227.
- 60. Kouros N (2013) HPV vaccine working in Australia. Monash bioethics review 31: 8–9.